1. Krishnamurthy S, Vasudeva SB, Vijayasarathy S. Salivary 
gland disorders: A comprehensive review. World J Stomatol 
2015;4: 56-71.
2. Brooks KG, Thompson DF. A review and assessment of 
drug‑induced parotitis. Ann Pharmacother 2012;46:1688‑99.
3. Gislon Da Silva RM. Captopril‑induced bilateral parotid and 
submandibular sialadenitis. Eur J Clin Pharmacol 2004;60:449‑53.
4. Chauhan V, Negi RC, Sharma A, Gupta S, Mokta J, Verma B,et al. Enalaprilat induced acute parotitis. J Assoc Physicians 
India 2008;56:128‑9.
5. Moss JR, Zanation AM, Shores CG. ACE inhibitor associated 
recurrent intermittent parotid gland swelling. Otolaryngol 
Head Neck Surg 2005;133:992‑4.
6. Atkinson W, Wolfe S, Hamborsky J. Centers for Disease 
Control and Prevention Epidemiology and Prevention of 
Vaccine‑Preventable Diseases, “Pink Book,”. Washington, DC: 
Public Health Foundation; 2011.
7. Gültuna S, Usküdar O, Yüksel I, Basar O, Köklü S. Transient 
parotitis after conscious sedation for endoscopy. Endoscopy 
2009;41 Suppl 2:E53.
8. Kenningham J. An unusual case of postoperative facial 
swelling. Anaesthesia 2000;55:601‑2.
9. Suki WN, Massry SG. Therapy of Renal Diseases and Related 
Disorders. Boston: Kluwer Academic Publishers; 1991.
10. Drummer OH, Workman BS, Miach PJ, Jarrott B, Louis WJ. 
The pharmacokinetics of captopril and captopril disulfide 
conjugates in uraemic patients on maintenance dialysis: 
Comparison with patients with normal renal function. Eur J 
Clin Pharmacol 1987;32:267‑71.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, 
et al. A method for estimating the probability of adverse drug 
reactions. Clin Pharmacol Ther 1981;30:239‑45.